Masashi Miyauchi

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency”.

DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.26.620318

N/A

0DataRank · unranked

3 citations

Daiki Karigane, Eleanor Hilgart, Amy C. Fan, Kensuke Kayamori, Masashi Miyauchi +13 more

Highly efficient in vivo hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virus

Molecular Therapy — Methods & Clinical Development(2025)10.1016/j.omtm.2025.101438

N/A

0DataRank · unranked

4 citations

Shota Homma, Anais K. Amaya, Carla Dib, Sriram Vaidyanathan, Tze-Kai Tan +12 more

DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1604

N/A

0DataRank · unranked

2 citations

Daiki Karigane, Eleanor Hilgart, Amy C. Fan, Kensuke Kayamori, Masashi Miyauchi +13 more